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Isolation and identification of potent anti-tumor compounds from medicinal plants, has motivated 
researchers to screen plant species for anti-tumor effects. Regarding the traditional utilization of 
Sambucus ebulus, Iranian native botany and its active ingredients (e.g. ebulitin and ebulin 1), 
cytotoxicity of ethyl acetate extract from S. ebulus (SEE) on HepG2 and CT26 cancer cell lines was 
investigated. Also, protective effects of vitamins C and E against SEE-induced cytotoxicity on normal 
cell lines were studied. Cytotoxicity of SEE on cancer (HepG2 and CT26) and normal (CHO and rat 
fibroblast) cell lines was evaluated by MTT assay. IC50 of SEE on the cell lines was assessed. 
Furthermore, IC50 of SEE on normal cell lines with exposure to vitamins C, E and C+E was studied. SEE 
possessed lower IC50 in cancer cell lines compared with normal cell lines. It manifested high 
cytotoxicity that can act as anticancer compound. Also, cytotoxicity of SEE on normal cell lines in 
presence of vitamins C+E, E and C decreased. The results demonstrate that SEE is an effective 
cytotoxic agent on liver and colon cancer cells and suggest that vitamins C and E may protect normal 
cells, when SEE were used in cancer therapy in future. 
 





At present time, utilization of pharmaceutical plants (es-
pecially native plants) in treatment of diseases has been 
of specific importance. Isolation and identification of 
some potent anti-tumor compounds, such as colchicine, 
Vinca alkaloids and taxol, as natural anticancer com- 
pounds, has encouraged scientists to screen different 
parts of plant species against cancer cell lines (Shokrzadeh 
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Abbreviations: SEE, Sambucus ebulus extract; HepG2, 
human hepatocarcinoma; CT26, human colon carcinoma; CHO, 
Chinese hamster ovary; IC50, inhibition concentration of half of 
cells; MTT, 3 -(4, 5 -dimethylthiazol- 2 -yl)- 2, 5 –diphenyltetra-
zolium bromide; RIP, ribosome inactivating protein. 
2001; Van Uden, 1992; Huang, 1986).  
In Iranian folk medicine, the leaves and rhizomes of 
Sambucus ebulus have been used topically for curing 
inflammatory related diseases. S. ebulus (Elderberry) 
from the family Adoxaceae, extensively grows in the Nor-
thern regions of Iran and consists of several active ingre-
dients, such as flavonoids, steroid substances, car-diac 
glycosides, tannins, caffeic acid derivatives and other 
isolated substances (Shokrzadeh and Saeedi Saravi, 2010; 
Ahmadiani et al., 1998; Ghannadi and Ghassemi-Dehkordi, 
1997; de Benito et al., 1995; Pribela et al., 1992; Petkov, 
1986). Also, S. ebulus consists of ebulitin (RIP-I, ribosome 
inactivating protein) and ebulin1 (RIP-II), which have 
selective cytotoxicity on mammalian, fungal and bacterial 
cells. Ebulitin and ebulin 1 inactivate translation via de-
purination of 28S-rRNA and as a result, inhibit protein   





Benito et al., 1995; Barbieri et al., 1993). 
There are several reports concerning pharmacological 
properties of the plant S. ebulus, such as the anti-inflam-
matory, antinociceptive, anti hemorrhoid, anti Heli-
cobacter pylori and anti-rheumatic effects in traditional 
medicine (Saeedi Saravi and Shokrzadeh, 2009a, b; 
Ebrahimzadeh et al., 2007; Tuzlaci and Tolon, 2000; 
Mirhaydar, 1994; Yesilada et al., 1999a, 1999b; 
Guarrera, 1999; Petkov, 1986; Samsamshariat et al., 
1981; Zargari, 1981; Ognyanov et al., 1979).  
Here, we address whether S. ebulus extract (SEE) has 
cytotoxic effect on cancer cell lines. On the other hand, 
the evaluation of role of vitamins C and E, as anti-oxidant 
compounds on prevention of SEE-induced cytotoxicity on 
normal cell lines was also performed. 
 
 
MATERIALS AND METHODS 
 
Preparation of extract from Sambucus ebulus 
 
Fruits of S. ebulus were collected from 15
th
 km of Farah Abad road, 
Sari, Iranian province Mazandaran in August and September 2007. 
Botanical identification was confirmed by department of Pharma-
cognosy. A voucher specimen (No. 74) has been deposited in Sari 
faculty of Pharmacy. 
Fruits were dried at room temperature and coarsely ground 
before extraction. The weighed amount of dried and powdered 
sample (135 g) was fractionated by successive solvent extraction at 
room temperature by percolation with hexane, then ethyl acetate. 
The resulting ethyl acetate extract was separately concentrated 
over a rotary vacuum evaporator until a solid extract sample was 






MTT and DMEM/F12 medium culture were purchased from 
DEHean-Riedal (Germany) and GIBCO BRL, respectively. α-toco-
pherol (vitamin E) and Fresh Bovine Serum (FBS) were acquired 
from Sigma-Aldrich (St. Louis, MO, USA). All other reagents were of 





Human hepatocarcinoma HepG2 cells, human colon carcinoma 
CT26 cells, Chinese hamster ovary (CHO) cells and rat fibroblast 
cells were cultured at 37°C in DMEM/F12 (Gibco, BRL) supple-
mented with 10% fetal bovine serum (Gibco, BRL), 1 µl/ml ampho-
tricin B (Welcome, USA), 100 U/ml penicillin and 100 µg/ml 
streptomycin in a humidified atmosphere containing 5% CO2/95% 
air. To assess the cell cytotoxicity, following cell counting via MTT 
assay, the cells were seeded on 96-well culture plates at a density 
of 1 × 10
5
 cells/well and adapted for 12 h. The cells were then incu-
bated for 72 h, after which the cells were assayed for cell cytotoxi-







In MTT assay, cytotoxicity and cell viability was evaluated by mea-
suring the mitochondrial-dependent reduction of colourless 3 - (4, 5 




-dimethylthiazol 2 -yl)- 2, 5 -diphenyltetrazolium bromide (MTT) to a 
coloured blue formazan (Fotakis and Timbrell, 2006).  
50 μL of DMEM/F12 including 1 10
5
 cells were added to 3 
wells for each concentration of SEE and Etoposide. Then, the cells 
were incubated for 72 h. Then, the cell lines were treated with 50 μL 
of each 0 (solvent), 5, 25, 50, 100, 150, 250, 500, 1000 and 1500 
μg/ml of SEE and 50 μL of 0 (solvent), 5, 12.5, 25, 50, 100 μg/ml of 
Etoposide for 72 h and then incubated for 4 h in 30 μL of MTT for 
each well. After washing with sterile PBS, the intracellular formazan 
product was dissolved in dimethyl sulfoxide and the absorbance of 
each sample was spectrophotometrically measured at 490 and 630 
nm with a Bio-Rad 680 microplate reader. Following this procedure, 
IC50 of SEE on all cell lines was assesses via Prism ver.3 software. 
Furthermore, 50 μL of DMEM/F12 includ
5
 cells were 
added to 3 wells for determined concentration of SEE and 
Etoposide with exposure to vitamins C, E and C+E. The cell lines 
were treated with 50 μL of vitamins C (AC, DC), E (AE, DE) and 
C+E (AEC, DEC) for 48 h. Then, 50 μL of selected concentrations 
of SEE and Etoposide were added to each 3 vitamin-exposured 
wells for 72 h. The procedure was continued similar to the 
mentioned MTT assay. 
The specific doses of vitamin C, E, C+E are presented below: 
 
1. AC: 0.031 g vitamin C powder in 10 ml DDW (17.6 mM).  
2. DC: 2 ml of AC + 6 ml of PBS (2.2 mM). 
3. AE: 1 ml vitamin E in 4 ml of DMSO (465.11 mM). 
4. DE: 2 ml of AE + 6 ml of PBS (85.12 mM). 
5. AEC: 50 μL of AC + 50 μL of AE. 





All data and statistical significance were analyzed descriptively by 
means of one way-ANOVA, followed by Tukey-post test with p < 





Comparative analysis of MTT method to assess 
cytotoxicity in four different cell types treated with 
SEE 
 
Cellular damage induced by ethyl acetate extract of S. 
ebulus was assayed via MTT reduction activity and IC50 
of SEE on cancer and normal cell lines was assessed. A 
lower IC50 value is representative of the higher ability of a 
cytotoxic compound to cause cell death or inhibit cell 
growth. 
Exposure to SEE resulted in cell death toward apop-
tosis and necrosis in human hepatocarcinoma (HepG2) 
cells and in human colon carcinoma (CT26) cells. 
Apoptotic and necrotic cell death in HepG2 and CT26 
cancer cell lines, simply clarify in comparison with the 
SEE-untreated control cells. 
The results showed that the lowest and highest IC50 of 
the extract was evaluated on HepG2 (97.03 ± 1.52 µg/ml) 
and CHO (346.2 ± 3.02 µg/ml) cell lines; also, IC50 of the 
extract and Etoposide on normal cell lines was higher 
than that in cancer cell lines.  
The results showed that the extract of S. ebulus pos-
sesses higher IC50 in comparison with Etoposide on all 4 
normal and cancer cell lines (P < 0.05). Measured IC50 of 
SEE and Etoposide on the cancer and normal cell lines








Cancer cell line Normal cell line 
HepG2 (1C50*±SD)** CT26 (1C50*±SD)** CHO (1C50*±SD)** Fibroblast (1C50*±SD)** 
Sambucus ebulus (Ethyl 
acetate extract of fruits) 
97.03±1.52 152.70±3.36 346.2±3.02 312.29±2.01 
Etoposide 2.80±2.64 3.89±4.46 4.375±3.76 37.5±6.58 
 




are prepared in Table 1. Also, Figure 1 shows the cell 
viability and IC50 of SEE and Etoposide on four different 
cell lines.  
Sensitivity to SEE decreased according to the rank 
order of cells HepG2 > CT26 > Fibroblast > CHO. Other-
wise, IC50 of SEE in the 4 cell lines increased according 
to the rank order of cells CHO > Fibroblast > CT26 > 
HepG2. On the other hand, IC50 of Etoposide in the 4 cell 
lines increased according to the rank order of cells 
Fibroblast > CHO > CT26 > HepG2. 
 
 
Comparative analysis of protective effects of 
vitamins C and E on SEE-treated normal cell lines 
 
Regarding the results, marked decrease of cytotoxic 
activities of SEE and Etoposide was observed in the 
treated normal cells. It is well known that vitamin E plays 
an important role to amplify antioxidative defense system. 
To understand the underlying protective effect of the 
vitamins, we examined the effect of different concen-
trations of vitamins C, E and C+E, as described. The 
results showed that ascorbic acid (vitamin C), as water-
soluble antioxidant, did not significantly inhibit cell death 
caused by SEE and Etoposide (P > 0.05) (Table 2), 
whereas the lipid-soluble antioxidant α-tocopherol (vita-
min E) significantly blocked cell death. Almost complete 
protection of cells was also observed when α-tocopherol 
and ascorbic acid were added to SEE-treated normal 
cells (P < 0.001). The IC50 values for SEE on CHO and 
fibroblast normal cells, which were exposure to com-
bination of vitamins C and E (AEC, DEC), were higher 
than those of the corresponding vitamins E (AE, DE) and 
C (AC, DC), suggesting that AEC and DEC are more 
potent inhibitors. The protective effects of α- tocopherol 
and ascorbic acid in the 4 cell lines increased according 
to the rank order of vitamins AEC > DEC > AE > DE > AC 
> DC. As a result, IC50 values for SEE were significantly 
increased on CHO and fibroblast normal cells, but not 
significantly increase in IC50 of SEE on HepG2 and CT26 
cancer cells was observed, in comparison with control 





This study provides evidence that SEE acts as a cyto-
toxic agent in cancer cell lines. In cell culture model, SEE 
markedly reduced viable cancer cell count and caused 
cell death. This was supported by observed cytotoxicity in 
HepG2 and CT26 cells. Results from our study demon-
strate that IC50 of SEE on cancer cell lines was lower 
than that on normal cell lines. The higher IC50 of SEE and 
Etoposide on normal cells compared with cancer cells 
can be resulted from dysfunction of cellular organisms 
following cancer incidence, which cause higher rate of 
proliferation and increased cellular intake. Also, disorders 
in defensive systems of cancer cells and effusion 
insufficiency to escape toxic substances, can lead to 
inhibition of the growth of cancer cells in compa-rison 
with normal cells, via lower amounts of cytotoxic com-
pounds (Hultberg et al., 1999; Van Haaften et al., 2000). 
Few substances established as cytotoxic agent can be 
approved as anticancer drug; but regarding complex 
development of cancer, formulation of novel anticancer 
pharmaceuticals is difficult. So, compounds with cytotoxic 
effect are selected as first-ranked candi-date to discover 
anticancer drugs (Mongelli et al., 2000; Suffness and 
Pezzuto, 1991). The higher IC50 of Etoposide compared 
with SEE can be described regarding to pure active ingre-
dient of Etoposide (epi-podophylotoxin). But, SEE is a 
fractionated crude extract, which consists of a variety of 
pharmaceutical components with different medical effects 
and is not used as a pure compound. So, purification of 
SEE to reach ebulin 1 and ebulitin can resulted in high 
anti tumor potency. These findings suggest that SEE may 
be an important therapeutic strategy for the treatment of 
a variety of cancers in future. 
According to the results, it is noteworthy that radical-
scavenging antioxidants, such as α-tocopherol, complete-
ly blocked the cell death caused by SEE. α-Tocopherol and 
ascorbic acid-supplemented fibroblast and CHO normal 
cells showed a low loss of cell viability. α-Tocopherol was 
more effective than the corresponding ascorbic acid to 
decrease cytotoxicity of SEE. It may be ascribed primarily, 
if not solely, to the differences in the rate of cellular uptake. 
A higher uptake of α-tocopherol than ascorbic acid into 
culture cells has been reported (Saeedi Saravi and 
Shokrzadeh, 2008 a,b; Noguchi 2003; Sen et al., 2000). 
As a result, IC50 values for SEE and Etoposide, as posi-
tive control compound, significantly increased on normal 
cell lines which were treated with vitamins C and E. Also, 
combination of vitamins C and E (AEC) showed highest 
protective  effects on the normal cell lines, in comparison
































































































Figure 1. The evaluated IC50 (µg/ml) and viability of the cancer and normal cells exposure to ethyl acetate extract of Sambucus ebulus (SEE) 
and Etoposide. IC50 of SEE and cell viability of HepG2 cell line (A), CT26 cell line (B), Fibroblast cell line (C), CHO cell line (D), were 





with vitamins E (AE, DE) or vitamins C (AC, DC). The 
present study clearly shows that cell death was inhibited 
by various types of antioxidants with different functions, 
such as tocopherols and ascorbic acid, which inhibit lipid 
peroxidation in the membranes, respectively (Saeedi 
Saravi and Shokrzadeh, 2009b). In conclusion, vitamins 
C and E were suggested for prevention of oxidative 
effects of the ethyl acetate extract of S. ebulus, when





































Figure 2. The evaluated IC50 (µg/ml) ethyl acetate extract of Sambucus ebulus (SEE) 
and Etoposide on HepG2, CT26, Fibroblast and CHO cell lines, which were treated with 




Table 2. The evaluated IC50 (µg/ml) of ethyl acetate extract of Sambucus ebulus and Etoposide on normal and cancer cell lines, 




IC50 in cancer cell lines IC50 in normal cell lines 
HepG2 (µg/ml)* CHO (µg/ml)* Fibroblast (µg/ml)* CT26 (µg/ml)* 
Control 97.03 ± 8.3 346.2 ± 22.65 312.29 ± 18.93 152.7 ± 10.86 
AC 121.57 ± 6.47 357.36 ± 25.43 322.38 ± 17.12 169.7 ± 8.09 
DC 107.6 ± 9.2 352.1± 18.92 317.89 ± 16.03 159.65 ± 5.2 
AE 137.12 ± 5.73 372.39 ± 26.75 338.47 ± 17.74 171.49 ± 9.34 
DE 132.09 ± 2.87 363.48 ± 23.54 330.09 ± 17.83 160.36 ± 6.27 
AEC 153.46 ± 10.72 384.66 ± 30.1 347.38 ± 18.09 183.54 ± 7.81 
DEC 142.25 ± 7.1 375.24 ± 27.36 340.48 ± 17.63 174.14 ± 5.35 
 
*µg/ml; **P< 0.05 
AC: ascorbic acid (17.6 mM); DC: ascorbic acid (2.2 mM); AE: α-Tocopherol (465.11 mM); DE: α-Tocopherol (85.12 mM); AEC: 50 μl of AC 
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